Compare APLD & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APLD | QGEN |
|---|---|---|
| Founded | 2001 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 9.0B |
| IPO Year | 2021 | 1998 |
| Metric | APLD | QGEN |
|---|---|---|
| Price | $23.41 | $45.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 16 |
| Target Price | ★ $64.03 | $47.73 |
| AVG Volume (30 Days) | ★ 15.8M | 2.0M |
| Earning Date | 10-07-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 6.20% |
| EPS Growth | ★ 21.55 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $611,311,000.00 | N/A |
| Revenue This Year | $45.14 | $2.18 |
| Revenue Next Year | $133.54 | $5.06 |
| P/E Ratio | ★ N/A | $24.01 |
| Revenue Growth | ★ 167.45 | N/A |
| 52 Week Low | $19.01 | $32.53 |
| 52 Week High | $50.73 | $57.82 |
| Indicator | APLD | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 39.64 | 57.10 |
| Support Level | $20.00 | $45.39 |
| Resistance Level | $29.08 | $49.43 |
| Average True Range (ATR) | 1.30 | 1.14 |
| MACD | -0.18 | 0.09 |
| Stochastic Oscillator | 12.90 | 67.60 |
Applied Digital Corp is a U.S. based designer, developer, owner, and operator of large-scale, purpose-built data centers engineered to support high-performance computing (HPC) workloads, including artificial intelligence (AI), machine learning, and other accelerated-compute applications. It design, build, and operate high-performance, sustainably engineered data centers which it refer to as AI factories and deliver that capacity to investment-grade hyper scalers and other compute customers under long-term lease and hosting arrangements. The company has two segments Data Center Hosting Business, and HPC Hosting Business. The company generates majority of revenue from Data Center Hosting Business segment. Its solutions are Digital Infrastructure, and AI Factories.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).